Y-mAbs Therapeutics, Inc. Deferred Offering Costs
Y-mAbs Therapeutics, Inc. had Deferred Offering Costs of $772.00 thousand as of 2017-12-31, per its 10-K filed 2019-03-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2019-03-22
- 2017-12-31: Deferred Offering Costs $772.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2017-12-31 | $772.00K 10-K · filed 2019-03-22 |